ArticleBMC public health2025
An epidemiological study of hepatitis virus infection in psychiatric patients in East China.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundsPsychiatric patients have been the focus of social attention, and they may be more susceptible to hepatitis viruses. This study aims to investigate the prevalence and influencing factors of hepatitis virus infection among psychiatric patients in East China.
methodsA total of 6,5911 newly admitted psychiatric patients at Shandong Daizhuang Hospital from 2017 to 2023 were included in this study. Test results of serum biomarkers for HBV and HCV infection were collected from psychiatric patients. Background information such as sex, age, ethnicity, marital status, occupation, residence, region, and types of psychosis were collected. Results of serum markers for hepatitis B and C were also collected from 23,628 non-psychiatric individuals.
resultsIn the study area, the HBV infection rate in psychiatric patients was 3.75% (95% CI: 3.46-3.74%) and showed a decreasing trend by year (p for trend = 0.000). The HCV infection rate in psychiatric patients was 0.23% (95% CI: 0.19-0.27%). The HBV infection rates differed among sex, age, marital status, occupation, residence, region, severity, and psychosis types. The HCV infection rates differed among age, marital status, occupation, and psychosis types. The HBV infection rate in psychiatric patients was positively skewed with age, being lowest in the age group of 5-15 years old and the highest in the age group of 36-40 years old, similar to the distribution of HBV infection in non-psychiatric patients. The HCV infection rate in psychiatric patients increased with age (p for trend = 0.000) and was similar to non-psychiatric patients (p for trend = 0.000). Compared with non-psychiatric patients, the "Mental and behavioural disorders due to use of alcohol", "Schizophrenia", "Mental disorders due to epilepsy", "Behavioural and emotional disorders with onset usually occurring in childhood and adolescence", "Obsessive-compulsive disorder", "Somatoform disorders" and "Depressive episode" become influencing factors for HBV infection. Compared with non-psychiatric patients, the "Dementia in other diseases classified elsewhere", "Depressive episode" become influencing factors for HCV infection. Being male, jobless and living in rural were risk factors for HBV infection, and urban became a risk factor for HCV infection. DISCUSSION AND
conclusionThe rate of HBV and HCV infection among psychiatric patients in this region have remained low. Gender, age, occupation, residence, and types of psychosis were identified as potential influencing factors for hepatitis virus infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.